| Oct 24 |
Precision BioSciences to Report Q3 Earnings: What's in the Cards?
|
| Oct 24 |
CTLT Stock Falls as Potential Hindrance to NVO Buyout Deal Increases
|
| Oct 24 |
Ozempic May Reduce the Risk of Alzheimer’s. That’s Huge for Novo Nordisk.
|
| Oct 24 |
Exclusive-Weight-loss drugs didn't curb health costs within two years, data show
|
| Oct 24 |
The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron and Biogen
|
| Oct 24 |
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
|
| Oct 23 |
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
|
| Oct 23 |
Nvidia Launches Danish Sovereign AI Supercomputer That Novo Nordisk Will Use
|
| Oct 23 |
Compounded GLP-1s are a 'symptom' of supply shortage: Ro CEO
|
| Oct 23 |
Update: Market Chatter: Catalent-Novo Holdings Deal Opposed by Roche CEO
|
